Curcumin, a component of golden spice: From bedside to bench and back

Biotechnology Advances

Volumn 32, Issue 6, 2014, Pages 1053-1064

  Prasad, Sahdeo ^a   Gupta, Subash C ^a   Tyagi, Amit K ^a   Aggarwal, Bharat B ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

Chronic diseases; Clinical trials; Curcumin; Curcumin analogs; Inflammation

Indexed keywords

GOLD; MEDICAL APPLICATIONS;

ANTI-INFLAMMATORIES; ANTICANCER ACTIVITIES; CHRONIC CONDITIONS; CHRONIC DISEASE; CLINICAL TRIAL; CURCUMIN; INFLAMMATION; MECHANISM OF ACTION;

DISEASES;

CURCUMA LONGA;

ANTIDIABETIC AGENT; ANTIINFLAMMATORY AGENT; ANTINEOPLASTIC AGENT; ANTIOXIDANT; CURCUMIN; PLANT EXTRACT;

ANIMAL; CELL LINE; CHEMISTRY; CURCUMA; HUMAN; SPICE;

ANIMALS; ANTI-INFLAMMATORY AGENTS; ANTINEOPLASTIC AGENTS; ANTIOXIDANTS; CELL LINE; CURCUMA; CURCUMIN; HUMANS; HYPOGLYCEMIC AGENTS; PLANT EXTRACTS; SPICES;

EID: 84921535683     PISSN: 07349750     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biotechadv.2014.04.004     Document Type: Review

References (134)

1. Abdel Aziz M.T., El-Asmar M.F., El-Ibrashy I.N., Rezq A.M., Al-Malki A.L., Wassef M.A., et al. Effect of novel water soluble curcumin derivative on experimental type-1 diabetes mellitus (short term study). Diabetol Metab Syndr 2012, 4:30.
2. Adhikary R., Mukherjee P., Kee T.W., Petrich J.W. Excited-state intramolecular hydrogen atom transfer and solvation dynamics of the medicinal pigment curcumin. J Phys Chem B 2009, 113:5255-5261.
3. Aggarwal B.B., Harikumar K.B. Potential therapeutic effects of curcumin, the anti-inflammatory agent, against neurodegenerative, cardiovascular, pulmonary, metabolic, autoimmune and neoplastic diseases. Int J Biochem Cell Biol 2009, 41:40-59.
4. Aggarwal B.B., Kumar A., Bharti A.C. Anticancer potential of curcumin: preclinical and clinical studies. Anticancer Res 2003, 23:363-398.
5. Aggarwal B.B., Shishodia S. Suppression of the nuclear factor-kappaB activation pathway by spice-derived phytochemicals: reasoning for seasoning. Ann N Y Acad Sci 2004, 1030:434-441.
6. Ahsan H., Parveen N., Khan N.U., Hadi S.M. Pro-oxidant, anti-oxidant and cleavage activities on DNA of curcumin and its derivatives demethoxycurcumin and bisdemethoxycurcumin. Chem Biol Interact 1999, 121:161-175.
7. Al-Amiery A.A., Kadhum A.A., Obayes H.R., Mohamad A.B.. Synthesis and antioxidant activities of novel 5-chlorocurcumin, complemented by semiempirical calculations. Bioinorg Chem. Appl 2013, 2013:354982.
8. Alwi I., Santoso T., Suyono S., Sutrisna B., Suyatna F.D., Kresno S.B., et al. The effect of curcumin on lipid level in patients with acute coronary syndrome. Acta Med Indones 2008, 40:201-210.
9. Anand P., Nair H.B., Sung B., Kunnumakkara A.B.., Yadav V.R., Tekmal R.R., et al. Design of curcumin-loaded PLGA nanoparticles formulation with enhanced cellular uptake, and increased bioactivity in vitro and superior bioavailability in vivo. Biochem Pharmacol 2010, 79:330-338.
10. Anand P., Sundaram C., Jhurani S., Kunnumakkara A.B.., Aggarwal B.B. Curcumin and cancer: an "old-age" disease with an "age-old" solution. Cancer Lett 2008, 267:133-164.
11. Anderson A.M., Mitchell M.S., Mohan R.S. Isolation of curcumin from turmeric. J Chem Educ 2000, 77:359-360.
12. Arun N., Nalini N. Efficacy of turmeric on blood sugar and polyol pathway in diabetic albino rats. Plant Foods Hum Nutr 2002, 57:41-52.
13. Aziz M.T., El Ibrashy I.N., Mikhailidis D.P., Rezq A.M., Wassef M.A., Fouad H.H., et al. Signaling mechanisms of a water soluble curcumin derivative in experimental type 1 diabetes with cardiomyopathy. Diabetol Metab Syndr 2013, 5:13.
14. Bagchi A. Extraction of Curcumin. IOSR J Environ Sci Toxicol Food Technol 2012, 1:1-16.
15. Balasubramanian S., Eckert R.L. Green tea polyphenol and curcumin inversely regulate human involucrin promoter activity via opposing effects on CCAAT/enhancer-binding protein function. J Biol Chem 2004, 279:24007-24014.
16. Baliga M.S., Joseph N., Venkataranganna M.V., Saxena A., Ponemone V., Fayad R. Curcumin, an active component of turmeric in the prevention and treatment of ulcerative colitis: preclinical and clinical observations. Food Funct 2012, 3:1109-1117.
17. Banji D., Pinnapureddy J., Banji O.J., Kumar A.R., Reddy K.N. Evaluation of the concomitant use of methotrexate and curcumin on Freund's complete adjuvant-induced arthritis and hematological indices in rats. Indian J Pharmacol 2011, 43:546-550.
18. Barthelemy S., Vergnes L., Moynier M., Guyot D., Labidalle S., Bahraoui E. Curcumin and curcumin derivatives inhibit Tat-mediated transactivation of type 1 human immunodeficiency virus long terminal repeat. Res Virol 1998, 149:43-52.
19. Basile V., Belluti S., Ferrari E., Gozzoli C., Ganassi S., Quaglino D., et al. bis-Dehydroxy-curcumin triggers mitochondrial-associated cell death in human colon cancer cells through ER-stress induced autophagy. PLoS One 2013, (8):e53664.
20. Bilmen J.G., Khan S.Z., Javed M.H., Michelangeli F. Inhibition of the SERCA Ca2+ pumps by curcumin. Curcumin putatively stabilizes the interaction between the nucleotide-binding and phosphorylation domains in the absence of ATP. Eur J Biochem 2001, 268:6318-6327.
21. Chandran B., Goel A. A randomized, pilot study to assess the efficacy and safety of curcumin in patients with active rheumatoid arthritis. Phytother Res 2012, 26:1719-1725.
22. Chang M.T., Tsai T.R., Lee C.Y., Wei Y.S., Chen Y.J., Chen C.R., et al. Elevating bioavailability of curcumin via encapsulation with a novel formulation of artificial oil bodies. J Agric Food Chem 2013, 61:9666-9671.
23. Chen C.Y., Yang W.L., Kuo S.Y. Cytotoxic activity and cell cycle analysis of hexahydrocurcumin on SW 480 human colorectal cancer cells. Nat Prod Commun 2011, 6:1671-1672.
24. Chen H., Wu J., Sun M., Guo C., Yu A., Cao F., et al. N-trimethyl chitosan chloride-coated liposomes for the oral delivery of curcumin. J Liposome Res 2012, 22:100-109.
25. Cheng K.K., Yeung C.F., Ho S.W., Chow S.F., Chow A.H., Baum L. Highly stabilized curcumin nanoparticles tested in an in vitro blood-brain barrier model and in Alzheimer's disease Tg2576 mice. AAPS J 2013, 15:324-336.
26. Chuengsamarn S., Rattanamongkolgul S., Phonrat B., Tungtrongchitr R., Jirawatnotai S. Reduction of atherogenic risk in patients with type 2 diabetes by curcuminoid extract: a randomized controlled trial. J Nutr Biochem 2014, 25:144-150.
27. Dairam A., Limson J.L., Watkins G.M., Antunes E., Daya S. Curcuminoids, curcumin, and demethoxycurcumin reduce lead-induced memory deficits in male Wistar rats. J Agric Food Chem 2007, 55:1039-1044.
28. Daube Ber Deut Chem Ges 1870, 3:609.
29. Dempe J.S., Pfeiffer E., Grimm A.S., Metzler M. Metabolism of curcumin and induction of mitotic catastrophe in human cancer cells. Mol Nutr Food Res 2008, 52:1074-1081.
30. Deodhar S.D., Sethi R., Srimal R.C. Preliminary study on antirheumatic activity of curcumin (diferuloyl methane). Indian J Med Res 1980, 71:632-634.
31. Dileep K.V., Tintu I., Sadasivan C. Molecular docking studies of curcumin analogs with phospholipase A2. Interdiscip Sci 2011, 3:189-197.
32. Dohare P., Garg P., Jain V., Nath C., Ray M. Dose dependence and therapeutic window for the neuroprotective effects of curcumin in thromboembolic model of rat. Behav Brain Res 2008, 193:289-297.
33. Dolai S., Shi W., Corbo C., Sun C., Averick S., Obeysekera D., et al. "Clicked" sugar-curcumin conjugate: modulator of amyloid-beta and tau peptide aggregation at ultralow concentrations. ACS Chem Neurosci 2011, 2:694-699.
34. Duan W., Yang Y., Yan J., Yu S., Liu J., Zhou J., et al. The effects of curcumin post-treatment against myocardial ischemia and reperfusion by activation of the JAK2/STAT3 signaling pathway. Basic Res Cardiol 2012, 107:263.
35. Dutta S., Padhye S., Priyadarsini K.I., Newton C. Antioxidant and antiproliferative activity of curcumin semicarbazone. Bioorg Med Chem Lett 2005, 15:2738-2744.
36. Egan M.E., Pearson M., Weiner S.A., Rajendran V., Rubin D., Glockner-Pagel J., et al. Curcumin, a major constituent of turmeric, corrects cystic fibrosis defects. Science 2004, 304:600-602.
37. El-Moselhy M.A., Taye A., Sharkawi S.S., El-Sisi S.F., Ahmed A.F. The antihyperglycemic effect of curcumin in high fat diet fed rats. Role of TNF-alpha and free fatty acids. Food Chem Toxicol 2011, 49:1129-1140.
38. Gafner S., Lee S.K., Cuendet M., Barthelemy S., Vergnes L., Labidalle S., et al. Biologic evaluation of curcumin and structural derivatives in cancer chemoprevention model systems. Phytochemistry 2004, 65:2849-2859.
39. Ghatak N., Basu N. Sodium curcuminate as an effective anti-inflammatory agent. Indian J Exp Biol 1972, 10:235-236.
40. Goel A., Kunnumakkara A.B.., Aggarwal B.B. Curcumin as "Curecumin": from kitchen to clinic. Biochem Pharmacol 2008, 75:787-809.
41. Guo L., Xing Y., Pan R., Jiang M., Gong Z., Lin L., et al. Curcumin protects microglia and primary rat cortical neurons against HIV-1 gp120-mediated inflammation and apoptosis. PLoS One 2013, 8:e70565.
42. Guo L.Y., Cai X.F., Lee J.J., Kang S.S., Shin E.M., Zhou H.Y., et al. Comparison of suppressive effects of demethoxycurcumin and bisdemethoxycurcumin on expressions of inflammatory mediators in vitro and in vivo. Arch Pharm Res 2008, 31:490-496.
43. Gupta S.C., Patchva S., Aggarwal B.B. Therapeutic roles of curcumin: lessons learned from clinical trials. AAPS J 2013, 15:195-218.
44. Harada K., Okiyoneda T., Hashimoto Y., Oyokawa K., Nakamura K., Suico M.A., et al. Curcumin enhances cystic fibrosis transmembrane regulator expression by down-regulating calreticulin. Biochem Biophys Res Commun 2007, 353:351-356.
45. Huang G., Xu Z., Huang Y., Duan X., Gong W., Zhang Y., et al. Curcumin protects against collagen-induced arthritis via suppression of BAFF production. J Clin Immunol 2013, 33:550-557.
46. Huang M.T., Ma W., Lu Y.P., Chang R.L., Fisher C., Manchand P.S., et al. Effects of curcumin, demethoxycurcumin, bisdemethoxycurcumin and tetrahydrocurcumin on 12-O-tetradecanoylphorbol-13-acetate-induced tumor promotion. Carcinogenesis 1995, 16:2493-2497.
47. Ibid.I.-G. 1870, 3:624.
48. Ireson C., Orr S., Jones D.J., Verschoyle R., Lim C.K., Luo J.L., et al. Characterization of metabolites of the chemopreventive agent curcumin in human and rat hepatocytes and in the rat in vivo, and evaluation of their ability to inhibit phorbol ester-induced prostaglandin E2 production. Cancer Res 2001, 61:1058-1064.
49. Ireson C.R., Jones D.J., Orr S., Coughtrie M.W., Boocock D.J., Williams M.L., et al. Metabolism of the cancer chemopreventive agent curcumin in human and rat intestine. Cancer Epidemiol Biomarkers Prev 2002, 11:105-111.
50. Ishizaki C., Oguro T., Yoshida T., Wen C.Q., Sueki H., Iijima M. Enhancing effect of ultraviolet A on ornithine decarboxylase induction and dermatitis evoked by 12-o-tetradecanoylphorbol-13-acetate and its inhibition by curcumin in mouse skin. Dermatology 1996, 193:311-317.
51. Ivanow-Gajewsky Ber Deut Chem Ges 1872, 5:1103.
52. Jacob J.N., Badyal D.K., Bala S., Toloue M. Evaluation of the in vivo anti-inflammatory and analgesic and in vitro anti-cancer activities of curcumin and its derivatives. Nat Prod Commun 2013, 8:359-362.
53. Jayaraj R.L., Tamilselvam K., Manivasagam T., Elangovan N. Neuroprotective effect of CNB-001, a novel pyrazole derivative of curcumin on biochemical and apoptotic markers against rotenone-induced SK-N-SH cellular model of Parkinson's disease. J Mol Neurosci 2013, 51:863-870.
54. Jeong C.W., Yoo K.Y., Lee S.H., Jeong H.J., Lee C.S., Kim S.J. Curcumin protects against regional myocardial ischemia/reperfusion injury through activation of RISK/GSK-3beta and inhibition of p38 MAPK and JNK. J Cardiovasc Pharmacol Ther 2012, 17:387-394.
55. Jimenez S.A., Gaidarova S., Saitta B., Sandorfi N., Herrich D.J., Rosenbloom J.C., et al. Role of protein kinase C-delta in the regulation of collagen gene expression in scleroderma fibroblasts. J Clin Invest 2001, 108:1395-1403.
56. Kannappan R., Gupta S.C., Kim J.H., Reuter S., Aggarwal B.B. Neuroprotection by spice-derived nutraceuticals: you are what you eat!. Mol Neurobiol 2011, 44:142-159.
57. Khopde S.M., Priyadarsini K.I., Guha S.N., Satav J.G., Venkatesan P., Rao M.N. Inhibition of radiation-induced lipid peroxidation by tetrahydrocurcumin: possible mechanisms by pulse radiolysis. Biosci Biotechnol Biochem 2000, 64:503-509.
58. Kim D.S., Park S.Y., Kim J.K. Curcuminoids from Curcuma longa L. (Zingiberaceae) that protect PC12 rat pheochromocytoma and normal human umbilical vein endothelial cells from betaA(1-42) insult. Neurosci Lett 2001, 303:57-61.
59. Kim H., Park B.S., Lee K.G., Choi C.Y., Jang S.S., Kim Y.H., et al. Effects of naturally occurring compounds on fibril formation and oxidative stress of beta-amyloid. J Agric Food Chem 2005, 53:8537-8541.
60. Kim J.H., Shim J.S., Lee S.K., Kim K.W., Rha S.Y., Chung H.C., et al. Microarray-based analysis of anti-angiogenic activity of demethoxycurcumin on human umbilical vein endothelial cells: crucial involvement of the down-regulation of matrix metalloproteinase. Jpn J Cancer Res 2002, 93:1378-1385.
61. Kita T., Imai S., Sawada H., Seto H. Isolation of dihydrocurcuminoids from cell clumps and their distribution in various parts of turmeric (Curcuma longa). Biosci Biotechnol Biochem 2009, 73:1113-1117.
62. Kumar A., Ahuja A., Ali J., Baboota S. Curcumin loaded nano globules for solubility enhancement: preparation, characterization and ex vivo release study. J Nanosci Nanotechnol 2012, 12:8293-8302.
63. Kumar S., Dubey K.K., Tripathi S., Fujii M., Misra K. Design and synthesis of curcumin-bioconjugates to improve systemic delivery. Nucleic Acids Symp Ser 2000, 75-76.
64. Kuttan R., Bhanumathy P., Nirmala K., George M.C. Potential anticancer activity of turmeric (Curcuma longa). Cancer Lett 1985, 29:197-202.
65. Kuttan R., Sudheeran P.C., Josph C.D. Turmeric and curcumin as topical agents in cancer therapy. Tumori 1987, 73:29-31.
66. Lai C.S., Wu J.C., Yu S.F., Badmaev V., Nagabhushanam K., Ho C.T., et al. Tetrahydrocurcumin is more effective than curcumin in preventing azoxymethane-induced colon carcinogenesis. Mol Nutr Food Res 2011, 55:1819-1828.
67. Lampe.V., Milobedzka.J. Studien uber Curcumin. Ber Deut Chem Ges 1913, 46:2235-2237.
68. Lee W.H., Loo C.Y., Bebawy M., Luk F., Mason R.S., Rohanizadeh R. Curcumin and its derivatives: their application in neuropharmacology and neuroscience in the 21st century. Curr Neuropharmacol 2013, 11:338-378.
69. Li C., Zhang Y., Su T., Feng L., Long Y., Chen Z. Silica-coated flexible liposomes as a nanohybrid delivery system for enhanced oral bioavailability of curcumin. Int J Nanomedicine 2012, 7:5995-6002.
70. Li F., Nitteranon V., Tang X., Liang J., Zhang G., Parkin K.L., et al. In vitro antioxidant and anti-inflammatory activities of 1-dehydro-[6]-gingerdione, 6-shogaol, 6-dehydroshogaol and hexahydrocurcumin. Food Chem 2012, 135:332-337.
71. Lian Y.T., Yang X.F., Wang Z.H., Yang Y., Yang Y., Shu Y.W., et al. Curcumin serves as a human kv1.3 blocker to inhibit effector memory T lymphocyte activities. Phytother Res 2013, 27:1321-1327.
72. Lin R., Chen X., Li W., Han Y., Liu P., Pi R. Exposure to metal ions regulates mRNA levels of APP and BACE1 in PC12 cells: blockage by curcumin. Neurosci Lett 2008, 440:344-347.
73. Lipecka J., Norez C., Bensalem N., Baudouin-Legros M., Planelles G., Becq F., et al. Rescue of DeltaF508-CFTR (cystic fibrosis transmembrane conductance regulator) by curcumin: involvement of the keratin 18 network. J Pharmacol Exp Ther 2006, 317:500-505.
74. Liu J.P., Feng L., Zhu M.M., Wang R.S., Zhang M.H., Hu S.Y., et al. The in vitro protective effects of curcumin and demethoxycurcumin in Curcuma longa extract on advanced glycation end products-induced mesangial cell apoptosis and oxidative stress. Planta Med 2012, 78:1757-1760.
75. Liu Y.L., Yang H.P., Gong L., Tang C.L., Wang H.J. Hypomethylation effects of curcumin, demethoxycurcumin and bisdemethoxycurcumin on WIF-1 promoter in non-small cell lung cancer cell lines. Mol Med Rep 2011, 4:675-679.
76. Loeber.C.C. De curcuma officinarum. Diss Inaug Halae 1748.
77. Manikandan R., Thiagarajan R., Beulaja S., Sudhandiran G., Arumugam M. Effect of curcumin on selenite-induced cataractogenesis in Wistar rat pups. Curr Eye Res 2010, 35:122-129.
78. Milobedzka J., Kostanecki S., Lampe V. Zur Kenntnis des Curcumins. Ber Deut Chem Ges 1910, 43:2163-2170.
79. Mishra S., Karmodiya K., Surolia N., Surolia A. Synthesis and exploration of novel curcumin analogues as anti-malarial agents. Bioorg Med Chem 2008, 16:2894-2902.
80. Murugan P., Pari L. Influence of tetrahydrocurcumin on hepatic and renal functional markers and protein levels in experimental type 2 diabetic rats. Basic Clin Pharmacol Toxicol 2007, 101:241-245.
81. Okada K., Wangpoengtrakul C., Tanaka T., Toyokuni S., Uchida K., Osawa T. Curcumin and especially tetrahydrocurcumin ameliorate oxidative stress-induced renal injury in mice. J Nutr 2001, 131:2090-2095.
82. Oppenheimer.A. Turmeric (curcumin) in biliary diseases. Lancet 1937, 229:619-621.
83. Padilla S.L., Rodriguez A., Gonzales M.M., Gallego G.J., Castano O.J. Inhibitory effects of curcumin on dengue virus type 2-infected cells in vitro. Arch Virol 2014, 159:573-579.
84. Pal A., Sung B., Bhanu Prasad B.A., Schuber P.T., Prasad S., Aggarwal B.B., et al. Curcumin glucuronides: assessing the proliferative activity against human cell lines. Bioorg Med Chem 2014, 22:435-439.
85. Pan M.H., Huang T.M., Lin J.K. Biotransformation of curcumin through reduction and glucuronidation in mice. Drug Metab Dispos 1999, 27:486-494.
86. Pan M.H., Lin-Shiau S.Y., Lin J.K. Comparative studies on the suppression of nitric oxide synthase by curcumin and its hydrogenated metabolites through down-regulation of IkappaB kinase and NFkappaB activation in macrophages. Biochem Pharmacol 2000, 60:1665-1676.
87. Pan Y., Zhu G., Wang Y., Cai L., Cai Y., Hu J., et al. Attenuation of high-glucose-induced inflammatory response by a novel curcumin derivative B06 contributes to its protection from diabetic pathogenic changes in rat kidney and heart. J Nutr Biochem 2013, 24:146-155.
88. Pari L., Murugan P. Protective role of tetrahydrocurcumin against erythromycin estolate-induced hepatotoxicity. Pharmacol Res 2004, 49:481-486.
89. Pari L., Murugan P. Tetrahydrocurcumin prevents brain lipid peroxidation in streptozotocin-induced diabetic rats. J Med Food 2007, 10:323-329.
90. Park C., Moon D.O., Choi I.W., Choi B.T., Nam T.J., Rhu C.H., et al. Curcumin induces apoptosis and inhibits prostaglandin E(2) production in synovial fibroblasts of patients with rheumatoid arthritis. Int J Mol Med 2007, 20:365-372.
91. Patil T.N., Srinivasan M. Hypocholesteremic effect of curcumin in induced hypercholesteremic rats. Indian J Exp Biol 1971, 9:167-169.
92. Prucksunand C., Indrasukhsri B., Leethochawalit M., Hungspreugs K. Phase II clinical trial on effect of the long turmeric (Curcuma longa Linn) on healing of peptic ulcer. Southeast Asian J Trop Med Public Health 2001, 32:208-215.
93. Ravindran J., Prasad S., Aggarwal B.B. Curcumin and cancer cells: how many ways can curry kill tumor cells selectively?. AAPS J 2009, 11:495-510.
94. Ryan J.L., Heckler C.E., Ling M., Katz A., Williams J.P., Pentland A.P., et al. Curcumin for radiation dermatitis: a randomized, double-blind, placebo-controlled clinical trial of thirty breast cancer patients. Radiat Res 2013, 180:34-43.
95. Sahebkar A. Are curcuminoids effective C-reactive protein-lowering agents in clinical practice? Evidence from a meta-analysis. Phytother Res 2014, 28:633-642.
96. Sandur S.K., Pandey M.K., Sung B., Ahn K.S., Murakami A., Sethi G., et al. Curcumin, demethoxycurcumin, bisdemethoxycurcumin, tetrahydrocurcumin and turmerones differentially regulate anti-inflammatory and anti-proliferative responses through a ROS-independent mechanism. Carcinogenesis 2007, 28:1765-1773.
97. Schraufstatter E., Bernt H. Antibacterial action of curcumin and related compounds. Nature 1949, 164:456.
98. Sharma O.P. Antioxidant activity of curcumin and related compounds. Biochem Pharmacol 1976, 25:1811-1812.
99. Sharma R.A., Euden S.A., Platton S.L., Cooke D.N., Shafayat A., Hewitt H.R., et al. Phase I clinical trial of oral curcumin: biomarkers of systemic activity and compliance. Clin Cancer Res 2004, 10:6847-6854.
100. Sheu M.J., Lin H.Y., Yang Y.H., Chou C.J., Chien Y.C., Wu T.S., et al. Demethoxycurcumin, a major active curcuminoid from Curcuma longa, suppresses balloon injury induced vascular smooth muscle cell migration and neointima formation: an in vitro and in vivo study. Mol Nutr Food Res 2013, 57:1586-1597.
101. Shim J.S., Lee J., Park H.J., Park S.J., Kwon H.J. A new curcumin derivative, HBC, interferes with the cell cycle progression of colon cancer cells via antagonization of the Ca2+/calmodulin function. Chem Biol 2004, 11:1455-1463.
102. Singh S., Aggarwal B.B. Activation of transcription factor NF-kappa B is suppressed by curcumin (diferuloylmethane) [corrected]. J Biol Chem 1995, 270:24995-25000.
103. Somparn P., Phisalaphong C., Nakornchai S., Unchern S., Morales N.P. Comparative antioxidant activities of curcumin and its demethoxy and hydrogenated derivatives. Biol Pharm Bull 2007, 30:74-78.
104. Soni K.B., Kuttan R. Effect of oral curcumin administration on serum peroxides and cholesterol levels in human volunteers. Indian J Physiol Pharmacol 1992, 36:273-275.
105. Sreejayan, Rao M.N. Curcuminoids as potent inhibitors of lipid peroxidation. J Pharm Pharmacol 1994, 46:1013-1016.
106. Srimal R.C., Dhawan B.N. Pharmacology of diferuloyl methane (curcumin), a non-steroidal anti-inflammatory agent. J Pharm Pharmacol 1973, 25:447-452.
107. Srimuangwong K., Tocharus C., Yoysungnoen Chintana P., Suksamrarn A., Tocharus J. Hexahydrocurcumin enhances inhibitory effect of 5-fluorouracil on HT-29 human colon cancer cells. World J Gastroenterol 2012, 18:2383-2389.
108. Srinivasan K.R. A chromatographic study of the curcuminoids in Curcuma longa, L. J Pharm Pharmacol 1953, 5:448-457.
109. Srinivasan M. Effect of curcumin on blood sugar as seen in a diabetic subject. Indian J Med Sci 1972, 26:269-270.
110. Steigerwalt R., Nebbioso M., Appendino G., Belcaro G., Ciammaichella G., Cornelli U., et al. Meriva(R), a lecithinized curcumin delivery system, in diabetic microangiopathy and retinopathy. Panminerva Med 2012, 54:11-16.
111. Strimpakos A.S., Sharma R.A. Curcumin: preventive and therapeutic properties in laboratory studies and clinical trials. Antioxid Redox Signal 2008, 10:511-545.
112. Sun J., Zhao Y., Hu J. Curcumin inhibits imiquimod-induced psoriasis-like inflammation by inhibiting IL-1beta and IL-6 production in mice. PLoS One 2013, 8:e67078.
113. Surh Y. Molecular mechanisms of chemopreventive effects of selected dietary and medicinal phenolic substances. Mutat Res 1999, 428:305-327.
114. Suskind D.L., Wahbeh G., Burpee T., Cohen M., Christie D., Weber W. Tolerability of curcumin in pediatric inflammatory bowel disease: a forced-dose titration study. J Pediatr Gastroenterol Nutr 2013, 56:277-279.
115. Swamy A.V., Gulliaya S., Thippeswamy A., Koti B.C., Manjula D.V. Cardioprotective effect of curcumin against doxorubicin-induced myocardial toxicity in albino rats. Indian J Pharmacol 2012, 44:73-77.
116. Takahashi M., Uechi S., Takara K., Asikin Y., Wada K. Evaluation of an oral carrier system in rats: bioavailability and antioxidant properties of liposome-encapsulated curcumin. J Agric Food Chem 2009, 57:9141-9146.
117. Taylor R.A., Leonard M.C. Curcumin for inflammatory bowel disease: a review of human studies. Altern Med Rev 2011, 16:152-156.
118. Tegenge M.A., Rajbhandari L., Shrestha S., Mithal A., Hosmane S., Venkatesan A. Curcumin protects axons from degeneration in the setting of local neuroinflammation. Exp Neurol 2013, 253C:102-110.
119. Tham C.L., Liew C.Y., Lam K.W., Mohamad A.S., Kim M.K., Cheah Y.K., et al. A synthetic curcuminoid derivative inhibits nitric oxide and proinflammatory cytokine synthesis. Eur J Pharmacol 2010, 628:247-254.
120. Topcu-Tarladacalisir Y., Akpolat M., Uz Y.H., Kizilay G., Sapmaz-Metin M., Cerkezkayabekir A., et al. Effects of curcumin on apoptosis and oxidoinflammatory regulation in a rat model of acetic acid-induced colitis: the roles of c-Jun N-terminal kinase and p38 mitogen-activated protein kinase. J Med Food 2013, 16:296-305.
121. Ukil A., Maity S., Karmakar S., Datta N., Vedasiromoni J.R., Das P.K. Curcumin, the major component of food flavour turmeric, reduces mucosal injury in trinitrobenzene sulphonic acid-induced colitis. Br J Pharmacol 2003, 139:209-218.
122. Vogel H.A., Pelletier J. Curcumin-biological and medicinal properties. J Pharma 1815, 2:50.
123. Vogel.A.J. J Pharm Chemie 1842, 3:20.
124. Wang W., Bernard K., Li G., Kirk K.L. Curcumin opens cystic fibrosis transmembrane conductance regulator channels by a novel mechanism that requires neither ATP binding nor dimerization of the nucleotide-binding domains. J Biol Chem 2007, 282:4533-4544.
125. Wang Y.J., Pan M.H., Cheng A.L., Lin L.I., Ho Y.S., Hsieh C.Y., et al. Stability of curcumin in buffer solutions and characterization of its degradation products. J Pharm Biomed Anal 1997, 15:1867-1876.
126. Wang Y.J., Thomas P., Zhong J.H., Bi F.F., Kosaraju S., Pollard A., et al. Consumption of grape seed extract prevents amyloid-beta deposition and attenuates inflammation in brain of an Alzheimer's disease mouse. Neurotox Res 2009, 15:3-14.
127. Wu J.C., Lai C.S., Badmaev V., Nagabhushanam K., Ho C.T., Pan M.H. Tetrahydrocurcumin, a major metabolite of curcumin, induced autophagic cell death through coordinative modulation of PI3K/Akt-mTOR and MAPK signaling pathways in human leukemia HL-60 cells. Mol Nutr Food Res 2011, 55:1646-1654.
128. Yadav V.R., Prasad S., Kannappan R., Ravindran J., Chaturvedi M.M., Vaahtera L., et al. Cyclodextrin-complexed curcumin exhibits anti-inflammatory and antiproliferative activities superior to those of curcumin through higher cellular uptake. Biochem Pharmacol 2010, 80:1021-1032.
129. Yang F., Lim G.P., Begum A.N., Ubeda O.J., Simmons M.R., Ambegaokar S.S., et al. Curcumin inhibits formation of amyloid beta oligomers and fibrils, binds plaques, and reduces amyloid in vivo. J Biol Chem 2005, 280:5892-5901.
130. Yang K.Y., Lin L.C., Tseng T.Y., Wang S.C., Tsai T.H. Oral bioavailability of curcumin in rat and the herbal analysis from Curcuma longa by LC-MS/MS. J Chromatogr B Analyt Technol Biomed Life Sci 2007, 853:183-189.
131. Yang Y., Duan W., Lin Y., Yi W., Liang Z., Yan J., et al. SIRT1 activation by curcumin pretreatment attenuates mitochondrial oxidative damage induced by myocardial ischemia reperfusion injury. Free Radic Biol Med 2013, 65:667-679.
132. Yodkeeree S., Chaiwangyen W., Garbisa S., Limtrakul P. Curcumin, demethoxycurcumin and bisdemethoxycurcumin differentially inhibit cancer cell invasion through the down-regulation of MMPs and uPA. J Nutr Biochem 2009, 20:87-95.
133. Zheng A., Li H., Wang X., Feng Z., Xu J., Cao K., et al. Anticancer effect of a curcumin derivative B63: ROS production and mitochondrial dysfunction. Curr Cancer Drug Targets 2013, [Nov 25] [Epub ahead].
134. Zhou G.Z., Zhang S.N., Zhang L., Sun G.C., Chen X.B. A synthetic curcumin derivative hydrazinobenzoylcurcumin induces autophagy in A549 lung cancer cells. Pharm Biol 2014, 52:111-116.